Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin S Braun

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Blood Advances|November 19, 2019
Paroxysmal cold hemoglobinuria successfully treated with complement inhibitionSarah A Lau-Braunhut, Hannah Stone, Griffin Collins, et al.
Science Translational Medicine|April 1, 2011
A MEK inhibitor abrogates myeloproliferative disease in Kras mutant miceNatalya Lyubynska, Matthew F Gorman, Jennifer O Lauchle, et al.
Blood|May 25, 2006
Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivoBenjamin S Braun, Joehleen A Archard, Jessica A G Van Ziffle, et al.
Cancer Cell|April 7, 2009
JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewalMarianne Santaguida, Koen Schepers, Bryan King, et al.
The Journal of Clinical Investigation|January 5, 2016
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant miceTiffany Chang, Kimberly Krisman, Emily Harding Theobald, et al.
The Journal of Clinical Investigation|December 11, 2012
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant miceTiffany Chang, Kimberly Krisman, Emily Harding Theobald, et al.
Plos Biology|March 20, 2009
Oncogenic Kras initiates leukemia in hematopoietic stem cellsAmit J Sabnis, Laurene S Cheung, Monique Dail, et al.
Blood|December 29, 2006
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cellsMargaret E M Van Meter, Ernesto Díaz-Flores, Joehleen A Archard, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2003
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorderBenjamin S Braun, David A Tuveson, Namie Kong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agentsMonique Dail, Qing Li, Andrew McDaniel, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Blood Advances|November 19, 2019
Paroxysmal cold hemoglobinuria successfully treated with complement inhibitionSarah A Lau-Braunhut, Hannah Stone, Griffin Collins, et al.
Science Translational Medicine|April 1, 2011
A MEK inhibitor abrogates myeloproliferative disease in Kras mutant miceNatalya Lyubynska, Matthew F Gorman, Jennifer O Lauchle, et al.
Blood|May 25, 2006
Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivoBenjamin S Braun, Joehleen A Archard, Jessica A G Van Ziffle, et al.
Cancer Cell|April 7, 2009
JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewalMarianne Santaguida, Koen Schepers, Bryan King, et al.
The Journal of Clinical Investigation|January 5, 2016
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant miceTiffany Chang, Kimberly Krisman, Emily Harding Theobald, et al.
The Journal of Clinical Investigation|December 11, 2012
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant miceTiffany Chang, Kimberly Krisman, Emily Harding Theobald, et al.
Plos Biology|March 20, 2009
Oncogenic Kras initiates leukemia in hematopoietic stem cellsAmit J Sabnis, Laurene S Cheung, Monique Dail, et al.
Blood|December 29, 2006
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cellsMargaret E M Van Meter, Ernesto Díaz-Flores, Joehleen A Archard, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2003
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorderBenjamin S Braun, David A Tuveson, Namie Kong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agentsMonique Dail, Qing Li, Andrew McDaniel, et al.
Pageof 4